HNO International, Inc. Releases Q1 2026 Financials: Key Takeaways for Investors

HNO International, Inc. has published its quarterly report for the period ended January 31, 2026. The unaudited financial statements and accompanying notes provide significant insights into the company’s financial health, capital structure, and recent equity activities. Below, we break down the key points and highlight crucial information for shareholders and potential investors.

1. Key Financial Highlights

• Net Loss Narrows Significantly:
  • The company reported a net loss of \$182,069 for the three months ended January 31, 2026, a dramatic improvement compared to the net loss of \$5,461,393 for the same period in the previous year.
  • Basic and diluted net loss per share for Q1 2026 was \$0.00, reflecting the reduction in losses and a substantially reduced share count compared to last year.
• Share Structure and Capital Changes:
  • Common shares outstanding at January 31, 2026: 101,821,989 (up from 100,795,491 at October 31, 2025).
  • Preferred Stock, Series A: 5,000,000 shares outstanding.
  • Preferred Stock, Series B: 360,000 shares outstanding.
  • No value assigned to Preferred Stock on the balance sheet, indicating either zero or nominal par value for these classes.
• Significant Equity Transactions:
  • During the quarter, the company issued 193,164 common shares upon full conversion of a convertible promissory note, extinguishing this liability from the balance sheet.
  • Regulation A and Regulation D stock issuances brought in new cash: 333,334 shares (\$334) issued for cash under Regulation A, and 500,000 shares (\$500) under Regulation D. These capital raises are modest but indicate ongoing access to equity financing.
  • Proceeds from sale of common stock (including subscriptions payable) totaled \$67,500 for the quarter.
  • Proceeds from related party advances: \$130,000 in the quarter, an important source of liquidity.
• Balance Sheet and Capital Deficit:
  • Total assets as of January 31, 2026: \$1,731,038.
  • Total liabilities: \$3,086,637, resulting in a stockholders’ deficit of (\$1,697,073).
  • Accumulated deficit increased to \$52,232,259, reflecting cumulative operating losses.
  • Additional paid-in capital stood at \$50,411,504, highlighting significant historical equity investment.
  • Share subscription receivable remained at (\$13,750), unchanged from the prior quarter.
• Cash Position and Liquidity:
  • Cash at the end of the period: \$1,038.
  • Despite new equity and related party financing, cash balances remain extremely low, raising ongoing concerns about liquidity.
  • Operating cash flows for the quarter were negative, with the deficit primarily covered by related party advances and new equity.
• Other Notable Events:
  • No shares were cancelled under a share exchange agreement in the current quarter (compared to \$360,000 cancellation in the previous year).
  • The company is a “smaller reporting company” and “non-accelerated filer,” and is not an emerging growth company or shell company.
  • All required SEC filings and electronic data submissions have been made timely.
  • No securities are listed for trading on any exchanges.

2. Potentially Price-Sensitive and Shareholder-Impacting Information

• Improvement in Net Loss: The sharp reduction in net loss compared to the previous year may be viewed positively by investors, suggesting operational improvements or reduced extraordinary expenses.
• Extinguishment of Convertible Debt: The full conversion of a convertible promissory note and the corresponding elimination of this liability reduces future dilution risk and improves the balance sheet.
• Ongoing Equity Issuance at Nominal Values: The company continues to rely on frequent small-scale equity offerings at very low prices to fund operations. While this provides capital, it is highly dilutive and may suppress future share price appreciation unless operations improve.
• Persistent Going Concern Risks: The extremely low cash balance (\$1,038) and ongoing operating losses point to continued financial risk. The company is dependent on related party advances and new equity to sustain operations.

3. Investor Considerations

• HNO International remains in a fragile financial condition with a significant stockholders’ deficit and negative operating cash flows. The company’s ability to continue as a going concern will depend on successful additional capital raises or a turnaround in operations.
• While the improvement in net loss is encouraging, the dilution from ongoing equity raises at nominal values, and reliance on related party funding, require careful monitoring.
• There are no listed securities for trading, and the company is not subject to the heightened reporting obligations of larger filers.
• No indication is given of any major new business wins, products, or strategic shifts in this quarter.

Outlook

Investors should watch for future capital raises, changes in operational performance, and management’s ability to address the company’s liquidity and deficit position. Any reversal in trends, significant funding, or business developments could materially affect the company’s valuation.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should consult the company’s full filings and their financial advisor before making investment decisions. All information is based on the company’s Form 10-Q for the quarter ended January 31, 2026.

View HNO International, Inc. Historical chart here